pharma · Hepatitis B · Mixed Dyslipidemia · ARWR
Arrowhead Pharmaceuticals Ireland
Arrowhead Pharmaceuticals Ireland Limited
Arrowhead Pharmaceuticals Ireland clinical programs — 18 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 177 E Colorado Blvd, Suite 700, Pasadena, California 91105, US
- Employees
- 746
- Programs
- 63
- Drugs
- 34
- Patents
- 126
Arrowhead Pharmaceuticals Ireland projects
18 ClinicalTrials.gov programs sponsored by Arrowhead Pharmaceuticals Ireland.
Arrowhead Pharmaceuticals Ireland has 18 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Hypertriglyceridemia (HTG)
1 trial -
ARO-APOC3 PFS, Plozasiran Injection Placebo
Arrowhead Pharmaceuticals Ireland Limited
Hypertriglyceridemia
1 trial -
ARO-APOC3 PFS, Plozasiran Injection Placebo
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
AROAPOC3-3001
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia Syndrome (FCS)
1 trial -
Calcium carbonate
Arrowhead Pharmaceuticals Ireland Limited
Uterine Contraction
1 trial -
Placebo of Zodasiran, ARO-ANG3
Arrowhead Pharmaceuticals Ireland Limited
Homozygous Familial Hypercholesterolemia (HoFH)
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia Syndrome
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Severe Hypertriglyceridemia
1 trial -
Plozasiran Injection
Arrowhead Pharmaceuticals Ireland Limited
Hypertriglyceridemia
2 trials -
Plozasiran Injection
Arrowhead Pharmaceuticals Ireland Limited
Severe Hypertriglyceridemia
2 trials -
Plozasiran Injection Placebo, ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
Plozasiran Injection Placebo, ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
Statins
Arrowhead Pharmaceuticals Ireland Limited
Intracerebral Hemorrhage
1 trial -
Tranexamic Acid
Arrowhead Pharmaceuticals Ireland Limited
Hemorrhagic Shock
1 trial -
Venofer 200 MG Per 10 ML Injection
Arrowhead Pharmaceuticals Ireland Limited
Iron Deficiency Anemia of Pregnancy
1 trial -
Zodasiran
Arrowhead Pharmaceuticals Ireland Limited
Homozygous Familial Hypercholesterolemia
1 trial -
zodasiran Injection
Arrowhead Pharmaceuticals Ireland Limited
Homozygous Familial Hypercholesterolemia
1 trial
Frequently asked questions
How many clinical projects does Arrowhead Pharmaceuticals Ireland have?
18 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.